Download PDF
Thromb Haemost 1986; 56(03): 308-310
DOI: 10.1055/s-0038-1661673
Original Article
Schattauer GmbH Stuttgart

Verapamil Inhibits Platelet Aggregation by a Calcium-Independent Mechanism

Giovanni Bonadonna
The Institute of Chemistry and Clinical Microscopy, University of Verona, Verona, Italy
,
Clara Lechi
The Institute of Chemistry and Clinical Microscopy, University of Verona, Verona, Italy
,
Paola Corradini
The Institute of Chemistry and Clinical Microscopy, University of Verona, Verona, Italy
,
Daniela Sinigaglia
The Institute of Chemistry and Clinical Microscopy, University of Verona, Verona, Italy
,
Piero De Togni
*   The Institute of General Pathology, University of Verona, Verona, Italy
,
Grzeskowiak Miroslawa
*   The Institute of General Pathology, University of Verona, Verona, Italy
› Author Affiliations
Further Information

Publication History

Received 06 May 1986

Accepted 01 September 1986

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

We studied the inhibitory effects of the calcium channel blocker verapamil both on platelet aggregation and intracellular calcium [Ca2+]i in platelets loaded with a fluorescent indicator (quin 2).

The inhibitory effects of verapamil on the platelet aggregation response to both thrombin and ionomycin were seen to be clearly dissociated from the verapamil-induced inhibition of the [Ca2+]i increase produced by these agonists. Verapamil-induced inhibition of platelet aggregation was also obtained when using the “calcium-independent” agonist phorbol-myristate acetate (PMA). It may be deduced that a calcium-independent mechanism plays a role in verapamil-induced inhibition of platelet aggregation. We postulate that this mechanism may operate via a protein-kinase C pathway.

Key words

Verapamil - Intracellular calcium - Platelet aggregation - Thrombin - Ionomycin
 

  • References

  • 1 Gerrard JM, Peterson DA, White JG. Calcium mobilization. In: Platelets in Biology and Pathology Gordon JL. (ed.). Vol. 5, pp. 407-436 Elsevier/North Holland Biomedical Press; Amsterdam: 1981
  • 2 Owen NE, Le Breton GC. Ca2+ mobilization in blood platelets as visualized by chlortetracycline fluorescence. Am J Physiol 1981; 241: H613-H619
    PubMedGoogle Scholar
  • 3 Jones CR, Pasanisi F, Elliot HL, Reid JL. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies. Br J Clin Pharmac 1985; 20: 191-196
    CrossrefPubMedGoogle Scholar
  • 4 Hallam TJ, Thompson NT, Scrutton MC, Rink TJ. The role of cytoplasmic free calcium in the responses of Quin-2 loaded human platelets to vasopressin. Biochem J 1984; 221: 897-901
    CrossrefPubMedGoogle Scholar
  • 5 Rink TJ, Sanchez A, Hallam TJ. Diacylglicerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets. Nature 1983; 305: 317-319
    CrossrefPubMedGoogle Scholar
  • 6 Castagna M, Takai Y, Kaibuchi K, Kikkawa V, Nishizuka Y. Direct activation of calcium activated phospholipid-dependent protein-kinase by tumor-promoting phorbol esters. J Biol Chem 1982; 257: 7847-7851
    PubMedGoogle Scholar
  • 7 Sanchez A, Hallam TJ, Rink TJ. Trifluoperazine and chlorpromazine block secretion from human platelets evoked at basal cytoplasmic free calcium by activators of C-kinase. FEBS Lett 1983; 164: 43-46
    CrossrefPubMedGoogle Scholar
  • 8 Della Bianca V, Grzeskowiak M, De Togni P, Cassatella M, Rossi F. Inhibition by verapamil of neutrophil responses to formyl-methionyl-leucyl-phenylalanine and phorbol-myristate acetate Mechanisms involving Ca2+ changes, cAMP and protein-kinase C. Biochim Biophys Acta 1985; 845: 223-226
    CrossrefPubMedGoogle Scholar